CardiaMed mechanical valve: mid-term results of a multicenter clinical trial
- PMID: 24585637
- DOI: 10.1177/0218492312464035
CardiaMed mechanical valve: mid-term results of a multicenter clinical trial
Abstract
Background: Prosthesis choice is a major concern in valvular surgery.
Methods: A multicenter clinical trial was performed to assess the efficacy and safety of the CardiaMed prosthetic heart valve. The study enrolled 420 patients who underwent mitral (209) or aortic (211) valve replacement from 2003 to 2004 at 7 institutions in Russia, and who were followed up from 2006 to 2011. The mean age was 52.2 ± 10.2 years (range, 12-78 years), 47.4% were female, and 99.05% completed the study.
Results: The maximum observation term was 7.5 years (2188.5 patient-years); 1081.6 patient-years for aortic and 1106.9 patient-years for mitral valve replacement. The overall 7-year survival rate was 85.1% ± 3.7%; 86.1% ± 4.8% and 84.4% ± 5.4% for aortic and mitral valve replacement, respectively. The 7-year freedom from valve-related death was 93.9% ± 3.7% and 94.5% ± 3.2% for aortic and mitral valve replacement, respectively. When early mortality (<30 days) was excluded, these rates were 94.8% ± 3.1% and 93.8% ± 3.82%, respectively. Linearized valve-dependent complication rates were determined for structural valve failure (0%/patient-year overall), thrombosis (0.63%/patient-year, all for mitral valve replacement), thromboembolic complications including transient neurologic deficits (0.13%/patient-year overall, 0.5%/patient-year for aortic valve replacement, 0.8%/patient-year for mitral valve replacement), hemorrhagic bleeding (0.64%/patient-year overall, 0.55%/patient-year for aortic valve replacement, 0.09%/patient-year for mitral valve replacement), prosthetic endocarditis (0.28%/patient-year overall, 0.28%/patient-year for aortic valve replacement, 0%/patient-year for mitral valve replacement), and hemolysis (0%/patient-year overall).
Conclusion: The CardiaMed mechanical heart valve prostheses meets world standards of safety and efficacy.
Keywords: Aortic valve; follow-up studies; heart valve prosthesis; heart valve prosthesis implantation; mitral valve.
Similar articles
-
Single center experience with the Sorin Bicarbon prosthesis: a 17-year clinical follow-up.J Thorac Cardiovasc Surg. 2014 Nov;148(5):2039-44. doi: 10.1016/j.jtcvs.2013.11.015. Epub 2013 Dec 9. J Thorac Cardiovasc Surg. 2014. PMID: 24332112
-
Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study.J Thorac Cardiovasc Surg. 2010 Nov;140(5):1053-8.e2. doi: 10.1016/j.jtcvs.2009.10.068. Epub 2010 May 23. J Thorac Cardiovasc Surg. 2010. PMID: 20546795
-
Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesis.J Heart Valve Dis. 2010 Jul;19(4):473-84. J Heart Valve Dis. 2010. PMID: 20845896
-
What type of valve is most appropriate for osteogenesis imperfecta patients?Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):499-504. doi: 10.1093/icvts/ivu152. Epub 2014 May 29. Interact Cardiovasc Thorac Surg. 2014. PMID: 24876219 Review.
-
Are valve repairs associated with better outcomes than replacements in patients with native active valve endocarditis?Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):1036-9. doi: 10.1093/icvts/ivu296. Epub 2014 Sep 3. Interact Cardiovasc Thorac Surg. 2014. PMID: 25185570 Review.
Cited by
-
The role of robotics in cardiac surgery: a systematic review.J Robot Surg. 2019 Feb;13(1):41-52. doi: 10.1007/s11701-018-0875-5. Epub 2018 Sep 25. J Robot Surg. 2019. PMID: 30255360
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical